269 related articles for article (PubMed ID: 27428423)
21. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
Wang G; Wang Y; Feng W; Wang X; Yang JY; Zhao Y; Wang Y; Liu Y
BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S22. PubMed ID: 18831788
[TBL] [Abstract][Full Text] [Related]
22. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A
Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554
[TBL] [Abstract][Full Text] [Related]
23. Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer.
Scott E; Garnham R; Cheung K; Duxfield A; Elliott DJ; Munkley J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897761
[TBL] [Abstract][Full Text] [Related]
24. RNA splicing and splicing regulator changes in prostate cancer pathology.
Munkley J; Livermore K; Rajan P; Elliott DJ
Hum Genet; 2017 Sep; 136(9):1143-1154. PubMed ID: 28382513
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of novel androgen-regulated genes in prostate cancer.
Velasco AM; Gillis KA; Li Y; Brown EL; Sadler TM; Achilleos M; Greenberger LM; Frost P; Bai W; Zhang Y
Endocrinology; 2004 Aug; 145(8):3913-24. PubMed ID: 15131019
[TBL] [Abstract][Full Text] [Related]
26. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
27. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.
Grosse L; Pâquet S; Caron P; Fazli L; Rennie PS; Bélanger A; Barbier O
Cancer Res; 2013 Dec; 73(23):6963-71. PubMed ID: 24121496
[TBL] [Abstract][Full Text] [Related]
28. Androgens down-regulate myosin light chain kinase in human prostate cancer cells.
Léveillé N; Fournier A; Labrie C
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):174-9. PubMed ID: 19429448
[TBL] [Abstract][Full Text] [Related]
29. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.
Vellaichamy A; Dezso Z; JeBailey L; Chinnaiyan AM; Sreekumar A; Nesvizhskii AI; Omenn GS; Bugrim A
PLoS One; 2010 Jun; 5(6):e10936. PubMed ID: 20532174
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
[TBL] [Abstract][Full Text] [Related]
31. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.
Dayon A; Brizuela L; Martin C; Mazerolles C; Pirot N; Doumerc N; Nogueira L; Golzio M; Teissié J; Serre G; Rischmann P; Malavaud B; Cuvillier O
PLoS One; 2009 Nov; 4(11):e8048. PubMed ID: 19956567
[TBL] [Abstract][Full Text] [Related]
33. Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases.
Hsiao JJ; Smits MM; Ng BH; Lee J; Wright ME
Sci Rep; 2021 Nov; 11(1):22208. PubMed ID: 34782677
[TBL] [Abstract][Full Text] [Related]
34. Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential.
Zimmer BM; Howell ME; Wei Q; Ma L; Romsdahl T; Loughman EG; Markham JE; Seravalli J; Barycki JJ; Simpson MA
Horm Cancer; 2016 Aug; 7(4):260-71. PubMed ID: 27307252
[TBL] [Abstract][Full Text] [Related]
35. Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells.
Munkley J; Lafferty NP; Kalna G; Robson CN; Leung HY; Rajan P; Elliott DJ
BMC Cancer; 2015 Jan; 15():9. PubMed ID: 25592066
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
[TBL] [Abstract][Full Text] [Related]
37. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis.
Waghray A; Feroze F; Schober MS; Yao F; Wood C; Puravs E; Krause M; Hanash S; Chen YQ
Proteomics; 2001 Oct; 1(10):1327-38. PubMed ID: 11721644
[TBL] [Abstract][Full Text] [Related]
38. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
[TBL] [Abstract][Full Text] [Related]
39. Androgen regulation of gene expression.
Lamont KR; Tindall DJ
Adv Cancer Res; 2010; 107():137-62. PubMed ID: 20399963
[TBL] [Abstract][Full Text] [Related]
40. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]